Phosphorus magnetic resonance spectroscopy studies in schizophrenia.
暂无分享,去创建一个
B. Cohen | D. Ongur | Bruce M Cohen | L. O'Connor | F. Du | Dost Ongur | Cagri Yuksel | Cuneyt Tegin | Lauren O'Connor | Fei Du | Ezgi Ahat | C. Yuksel | C. Tegin | Ezgi Ahat
[1] P. Williamson,et al. Longitudinal 4.0 Tesla 31P magnetic resonance spectroscopy changes in the anterior cingulate and left thalamus in first episode schizophrenia , 2009, Psychiatry Research: Neuroimaging.
[2] K Ugurbil,et al. Increase of creatine kinase activity in the visual cortex of human brain during visual stimulation: A 31p NMR magnetization transfer study , 1997, Magnetic resonance in medicine.
[3] J. Reichenbach,et al. Effects of olanzapine on 31P MRS metabolic markers in schizophrenia , 2013, Human psychopharmacology.
[4] T. Inubushi,et al. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia , 1994, Psychiatry Research: Neuroimaging.
[5] H. Sauer,et al. Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?—a 31P-MRS study on three different patient groups , 2002, Psychiatry Research: Neuroimaging.
[6] W. Kaiser,et al. 31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique—preliminary findings , 1997, Biological Psychiatry.
[7] B. Holub. Altered phospholipid metabolism in thrombin-stimulated human platelets. , 1984, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.
[8] H. Fukuzako,et al. Phosphorus magnetic resonance spectroscopy in schizophrenia: Correlation between membrane phospholipid metabolism in the temporal lobe and positive symptoms , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[9] M. Krams,et al. Impaired mitochondrial function in psychiatric disorders , 2012, Nature Reviews Neuroscience.
[10] A. Heerschap,et al. 31P Magnetic resonance spectroscopic imaging with polarisation transfer of phosphomono‐ and diesters at 3 T in the human brain: relation with age and spatial differences , 2010, NMR in biomedicine.
[11] T. Inubushi,et al. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia , 1995, Psychiatry Research: Neuroimaging.
[12] W. Kaiser,et al. Decreased energy demanding processes in the frontal lobes of schizophrenics due to neuroleptics? A 31P-magneto-resonance spectroscopic study , 1997, Psychiatry Research: Neuroimaging.
[13] B. Weschke,et al. 31Phosphorus Magnetic Resonance Spectroscopy in Late-Onset Tay-Sachs Disease , 2001, Journal of child neurology.
[14] T. Inubushi,et al. Frontal lobe membrane phospholipid metabolism and ventricle to brain ratio in schizophrenia: preliminary 31P-MRS and CT studies , 2000, European Archives of Psychiatry and Clinical Neuroscience.
[15] D. Laifenfeld,et al. Mitochondria, synaptic plasticity, and schizophrenia. , 2004, International review of neurobiology.
[16] Ewald Moser,et al. 7‐T MR—from research to clinical applications? , 2012, NMR in biomedicine.
[17] Ravi S. Menon,et al. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla , 2006, Psychiatry Research: Neuroimaging.
[18] M. Keshavan,et al. Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study. , 2004, The American journal of psychiatry.
[19] Increase of phosphodiesters during neuroleptic treatment of schizophrenics: a longitudinal 31P-magnetic resonance spectroscopic study , 1999, Biological Psychiatry.
[20] T. Asakura,et al. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging , 1992, Acta psychiatrica Scandinavica.
[21] B. Puri,et al. Cerebral metabolism in male patients with schizophrenia who have seriously and dangerously violently offended: a 31P magnetic resonance spectroscopy study. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.
[22] H. Sauer,et al. Antipsychotic drug effects on left prefrontal phospholipid metabolism: A follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients , 2012, Schizophrenia Research.
[23] Heinrich Sauer,et al. 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics—a study including 50 patients and 36 controls , 1998, Biological Psychiatry.
[24] P. Williamson,et al. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study , 1994, Schizophrenia Research.
[25] G. Fein,et al. Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: A 31Phosphorous magnetic resonance spectroscopic imaging study , 1995, Biological Psychiatry.
[26] M. Keshavan,et al. Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies , 1993, Schizophrenia Research.
[27] J. Lieberman,et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. , 1994, The American journal of psychiatry.
[28] H. Fukuzako,et al. 31P magnetic resonance spectroscopy of the medial temporal lobe of schizophrenic patients with neuroleptic-resistant marked positive symptoms , 2005, European Archives of Psychiatry and Clinical Neuroscience.
[29] Dennis Velakoulis,et al. Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. , 2005, Schizophrenia bulletin.
[30] M. Keshavan,et al. Developmental reflexes and 31P Magnetic Resonance Spectroscopy of basal ganglia in antipsychotic-naive schizophrenia , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[31] G. Fein,et al. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia , 1994, Biological Psychiatry.
[32] B. Cohen,et al. In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy. , 2014, JAMA psychiatry.
[33] P. Williamson,et al. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. , 1995, Archives of general psychiatry.
[34] H. Sauer,et al. Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a 31P chemical shift spectroscopic-imaging study , 2000, Biological Psychiatry.
[35] J. Yacubian,et al. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism , 2002, Schizophrenia Research.
[36] G. Fein,et al. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia , 1992, Biological Psychiatry.
[37] D Ongur,et al. Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder , 2015, Molecular Psychiatry.
[38] J. Waddington,et al. Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy , 1991, Biological Psychiatry.
[39] M. Keshavan,et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. , 1991, Archives of general psychiatry.
[40] Ravi S. Menon,et al. Region-specific changes in phospholipid metabolism in chronic, medicated schizophrenia , 2002, British Journal of Psychiatry.
[41] Timm Rosburg,et al. Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia , 2007, NeuroImage.
[42] S. Bluml,et al. Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo. , 1999, Journal of computer assisted tomography.
[43] Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia. , 1997, Journal of psychiatry & neuroscience : JPN.
[44] M Takigawa,et al. Changes in levels of phosphorus metabolites in temporal lobes of drug-naive schizophrenic patients. , 1999, The American journal of psychiatry.
[45] Ravi S. Menon,et al. Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia , 2004, British Journal of Psychiatry.
[46] Ann K. Shinn,et al. Gray matter volume in schizophrenia and bipolar disorder with psychotic features , 2012, Schizophrenia Research.
[47] M. Keshavan,et al. MRI volumetric and 31P MRS metabolic correlates of caudate nucleus in antipsychotic‐naïve schizophrenia , 2006, Acta psychiatrica Scandinavica.
[48] Peter Boesiger,et al. Assessment of absolute metabolite concentrations in human tissue by 31P MRS in vivo. Part I: Cerebrum, cerebellum, cerebral gray and white matter , 1994, Magnetic resonance in medicine.
[49] P. Williamson,et al. A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls , 1999, Biological Psychiatry.
[50] H. Fukuzako,et al. Haloperidol Improves Membrane Phospholipid Abnormalities in Temporal Lobes of Schizophrenic Patients , 1999, Neuropsychopharmacology.
[51] C. Pantelis,et al. Implications of Lipid Biology for the Pathogenesis of Schizophrenia , 2002, The Australian and New Zealand journal of psychiatry.
[52] T. Inubushi,et al. Multiple regression analysis of relationship between frontal lobe phosphorus metabolism and clinical symptoms in patients with schizophrenia , 1997, Psychiatry Research: Neuroimaging.
[53] A. Meyer-Lindenberg,et al. Altered phospholipid metabolism in schizophrenia: A phosphorus 31 nuclear magnetic resonance spectroscopy study , 2013, Psychiatry Research: Neuroimaging.
[54] Truman R. Brown,et al. In Vivo Measurement of Phosphorous Markers of Disease , 2004, Disease markers.
[55] J. Reichenbach,et al. Superior temporal metabolic changes related to auditory hallucinations: a 31P-MR spectroscopy study in antipsychotic-free schizophrenia patients , 2013, Brain Structure and Function.
[56] H. Fukuzako. Neurochemical Investigation of the Schizophrenic Brain by in Vivo Phosphorus Magnetic Resonance Spectroscopy , 2001, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[57] P. Williamson,et al. Progressive membrane phospholipid changes in first episode schizophrenia with high field magnetic resonance spectroscopy , 2012, Psychiatry Research: Neuroimaging.
[58] M. Keshavan,et al. High energy phosphate abnormalities normalize after antipsychotic treatment in schizophrenia: A longitudinal 31P MRS study of basal ganglia , 2010, Psychiatry Research: Neuroimaging.
[59] G. Fein,et al. Basal ganglia phosphorous metabolism in chronic schizophrenia. , 1995, The American journal of psychiatry.
[60] Matcheri S Keshavan,et al. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings–part I , 2000, Biological Psychiatry.
[61] M. Keshavan,et al. Membrane phospholipid abnormalities of basal ganglia in never-treated schizophrenia a 31P magnetic resonance spectroscopy study , 2003, Biological Psychiatry.
[62] D. Kupfer,et al. Biological correlates of slow wave sleep deficits in functional psychoses: 31P-magnetic resonance spectroscopy , 1995, Psychiatry Research.
[63] Ravi S. Menon,et al. Comparative study of proton and phosphorus magnetic resonance spectroscopy in schizophrenia at 4 Tesla , 2004, Psychiatry Research: Neuroimaging.
[64] P. Williamson,et al. Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. , 1991, Archives of general psychiatry.
[65] Takashi Ogino,et al. In vivo31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest , 2004, The European journal of neuroscience.
[66] H. Volz,et al. High-energy phosphates in the frontal lobe correlate with Wisconsin Card Sort Test performance in controls, not in schizophrenics: a 31phosphorus magnetic resonance spectroscopic and neuropsychological investigation , 1998, Schizophrenia Research.